These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31796840)

  • 41. [Clinical severity of hemolytic disease of the newborn due to ABO incompatibility].
    Paz M; Shile R; Stanetzky J; Rikover M; Naor S
    Harefuah; 1972 Feb; 82(4):157-60. PubMed ID: 5052935
    [No Abstract]   [Full Text] [Related]  

  • 42. [ABO-erythroblastosis demonstrated in twins].
    Speiser P; Rosenkranz A; Langer F
    Wien Med Wochenschr; 1968 Jun; 118(22):510-2. PubMed ID: 5751832
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of birth weight on the severity of hemolytic disease of the newborn due to ABO incompatibility.
    Gupte SC; Kothari J; Bhatia HM
    Indian Pediatr; 1975 Jun; 12(6):477-83. PubMed ID: 1237468
    [No Abstract]   [Full Text] [Related]  

  • 44. Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten.
    Maisels MJ
    Early Hum Dev; 2009 Nov; 85(11):727-32. PubMed ID: 19833460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 47. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia.
    Berkwitt A; Osborn R; Grossman M
    Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey.
    Hakan N; Zenciroglu A; Aydin M; Okumus N; Dursun A; Dilli D
    J Matern Fetal Neonatal Med; 2015 Sep; 28(13):1537-41. PubMed ID: 25182682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 50. Strategies for neonatal hyperbilirubinemia: a literature review.
    Wells C; Ahmed A; Musser A
    MCN Am J Matern Child Nurs; 2013; 38(6):377-82;quiz 383-4. PubMed ID: 24145492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks.
    Punaro E; Mezzacappa MA; Facchini FP
    J Pediatr (Rio J); 2011; 87(4):301-6. PubMed ID: 21655685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ABO INCOMPATIBILITY: A STUDY OF THE USE OF GROUP O ERYTHROCYTES IN AB PLASMA.
    GOLDARB DL; GINSBERG V; KAUFMAN M; ROBINSON MG; WATSON RJ
    Pediatrics; 1964 Nov; 34():664-9. PubMed ID: 14227646
    [No Abstract]   [Full Text] [Related]  

  • 54. [Personal experience with the use of light in paraphysiological neonatal hyperbilirubinemia and hemolytic disease of the newborn due to Rh and ABO factors].
    Salvioli GP; Dallacasa P
    Minerva Pediatr; 1972 Feb; 24(3):113-23. PubMed ID: 4622393
    [No Abstract]   [Full Text] [Related]  

  • 55. ABO INCOMPATIBILITY IN THE NEWBORN: A REVIEW OF CASES AND CURRENT CONCEPTS.
    MITCHELL JR
    J Iowa Med Soc; 1964 May; 54():235-8. PubMed ID: 14143966
    [No Abstract]   [Full Text] [Related]  

  • 56. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
    Yaseen H; Khalaf M; Rashid N; Darwich M
    J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bilirubin and brain injury].
    Takahashi S; Wada M; Kimura E
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):455-61. PubMed ID: 11057283
    [No Abstract]   [Full Text] [Related]  

  • 58. Hereditary spherocytosis in neonates with hyperbilirubinemia.
    Christensen RD; Henry E
    Pediatrics; 2010 Jan; 125(1):120-5. PubMed ID: 19948573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States.
    Yu TC; Nguyen C; Ruiz N; Zhou S; Zhang X; Böing EA; Tan H
    BMC Pediatr; 2019 Feb; 19(1):53. PubMed ID: 30744649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.